10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q1 2023

Filing Information

Form Type	10-Q
Accession Number	`0001638833-23-000070`
Period End Date	20230331
Filing Date	20230502
Fiscal Year	2023
Fiscal Period	Q1
XBRL Instance	sgry-20230331_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 84 Income Statement 55 Cash Flow Statement 62 Stockholders Equity 22 Comprehensive Income 12

Balance Sheet 84 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$382.70M	USD	Point-in-time
Accumulated depreciation on property and equipment	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization`	$374.30M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.31M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$245.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$282.90M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$456.30M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$452.90M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$71.80M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$71.40M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$31.40M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$29.30M	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$79.00M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$69.40M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$868.90M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	126.48M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$921.00M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	125.96M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $382.7 and $374.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$844.30M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $382.7 and $374.3, respectively	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$876.60M	USD	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	126.48M	shares	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.18B	USD	Point-in-time
Goodwill and other intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$4.25B	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$191.60M	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$190.30M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$279.10M	USD	Point-in-time
Right-of-use operating lease assets	`OperatingLeaseRightOfUseAsset`	$274.00M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$91.50M	USD	Point-in-time
Long-term deferred tax assets	`DeferredIncomeTaxAssetsNet`	$93.30M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$118.60M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$144.20M	USD	Point-in-time
Total assets	`Assets`	$6.68B	USD	Point-in-time
Total assets	`Assets`	$6.64B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$144.40M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$151.60M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$68.90M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$67.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$200.00M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$210.10M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$62.90M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$62.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$493.40M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$475.10M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.53B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.56B	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$268.80M	USD	Point-in-time
Right-of-use operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$271.40M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$80.20M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$75.40M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$345.80M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$330.20M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$342.00M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$341.50M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,310,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 126,480,483 and 125,960,834, respectively	`CommonStockValueOutstanding`	$1.30M	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 126,480,483 and 125,960,834, respectively	`CommonStockValueOutstanding`	$1.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.48B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$2.48B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$64.90M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$76.20M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-582.30M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-557.30M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$2.00B	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$1.96B	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$942.70M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$980.50M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.68B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.64B	USD	Point-in-time

Income Statement 55 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$596.20M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$666.20M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$178.90M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$202.20M	USD	1 Quarter
Supplies	`SuppliesExpense`	$188.40M	USD	1 Quarter
Supplies	`SuppliesExpense`	$171.60M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$74.60M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$63.60M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$21.40M	USD	1 Quarter
Lease expense	`OperatingAndFinanceLeaseExpense`	$20.00M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$37.30M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$45.60M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$532.20M	USD	1 Quarter
Cost of revenues	`OperatingCostsAndExpenses`	$471.40M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$29.50M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$32.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$33.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$27.40M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$12.50M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$7.10M	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.20M	USD	1 Quarter
Grant funds	`GrantRevenue`	$1.10M	USD	1 Quarter
Net loss (gain) on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-10.50M	USD	1 Quarter
Net loss (gain) on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$100.00K	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$3.10M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates	`IncomeLossFromEquityMethodInvestments`	$3.30M	USD	1 Quarter
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$-3.00M	USD	1 Quarter
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	1 Quarter
Litigation settlements	`GainLossRelatedToLitigationSettlement`	$32.80M	USD	Point-in-time
Other expense (income), net	`OtherNonrecurringIncomeExpense`	$-2.40M	USD	1 Quarter
Other expense (income), net	`OtherNonrecurringIncomeExpense`	$300.00K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$495.80M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$619.80M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$100.40M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$46.40M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-56.30M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-46.80M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$44.10M	USD	1 Quarter
(Loss) income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$-400.00K	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$-1.60M	USD	1 Quarter
Income tax benefit (expense)	`IncomeTaxExpenseBenefit`	$1.30M	USD	1 Quarter
Net income	`ProfitLoss`	$1.20M	USD	1 Quarter
Net income	`ProfitLoss`	$42.80M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$26.10M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Net (loss) income attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-24.90M	USD	1 Quarter
Net (loss) income attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$12.20M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.20	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$0.14	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.20	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$0.14	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	88.00M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	125.21M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	90.27M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	125.21M	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$1.20M	USD	1 Quarter
Net income	`ProfitLoss`	$42.80M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$33.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$27.40M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$9.00M	USD	1 Quarter
Non-cash lease expense	`OperatingLeaseExpense`	$8.60M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-6.50M	USD	1 Quarter
Non-cash interest expense, net	`NoncashInterestIncomeExpenseNet`	$-6.10M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$3.70M	USD	1 Quarter
Equity-based compensation expense	`ShareBasedCompensation`	$4.20M	USD	1 Quarter
Net loss (gain) on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-10.50M	USD	1 Quarter
Net loss (gain) on disposals, consolidations and deconsolidations	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$100.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-1.80M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.00M	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$200.00K	USD	1 Quarter
Equity in earnings of unconsolidated affiliates, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$900.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.00M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-8.80M	USD	1 Quarter
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-18.00M	USD	1 Quarter
Medicare accelerated payments and deferred governmental grants	`IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants`	$-1.20M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-3.80M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$-7.20M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$74.50M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$79.80M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.20M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$24.30M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$40.70M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$31.10M	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	-	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`ProceedsFromSaleOfProductiveAssets`	$8.00M	USD	1 Quarter
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	-	USD	1 Quarter
Purchases of equity investments	`PaymentsToAcquireEquityMethodInvestments`	$9.60M	USD	1 Quarter
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	1 Quarter
Proceeds from sales of equity investments	`ProceedsFromSaleOfEquityMethodInvestments`	$11.50M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$4.10M	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$9.30M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-47.10M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-70.70M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$17.00M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$15.90M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$11.90M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$15.90M	USD	1 Quarter
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	1 Quarter
Payments of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$1.30M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$41.90M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$36.20M	USD	1 Quarter
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$-3.10M	USD	1 Quarter
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$5.10M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.10M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$700.00K	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-41.20M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-43.70M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-37.40M	USD	1 Quarter
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-11.00M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$378.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$245.50M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$282.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$378.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$389.90M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$245.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$282.90M	USD	Point-in-time

Stockholders Equity 22 line items

Line Item	Tag	Value	Unit	Period
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Balance at beginning of period (shares)	`CommonStockSharesOutstanding`	126.48M	shares	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-6.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$32.20M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.70M	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$7.70M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-11.30M	USD	1 Quarter
Other Comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$56.80M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$-29.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$46.10M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$24.60M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$30.20M	USD	1 Quarter
Balance at end of period (shares)	`CommonStockSharesOutstanding`	125.96M	shares	Point-in-time
Balance at end of period (shares)	`CommonStockSharesOutstanding`	126.48M	shares	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.97B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.94B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$2.01B	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Net income	`ProfitLoss`	$1.20M	USD	1 Quarter
Net income	`ProfitLoss`	$42.80M	USD	1 Quarter
Derivative activity, tax	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax`	-	USD	1 Quarter
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$56.80M	USD	1 Quarter
Derivative activity, net of tax of $0	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-11.30M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-10.10M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$99.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$26.10M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$30.60M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$69.00M	USD	1 Quarter
Comprehensive (loss) income attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-36.20M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.